Professor, Department of Pathology
Professor, Department of Urology
The principal research focus of our group is to elucidate the molecular mechanism of hormonal (androgen and estrogen) receptors, their cofactors, and their target genes in the development of endocrine organs and malignancies, including breast and prostate cancers. In particular, we are interested in understanding the molecular mechanisms underlying the development of androgen-independent prostate cancer. A compelling element of our research is to understand how the expression and function of proteins in the stromal androgen receptor (AR) pathway influences the stromal-epithelial interactions, contributing to tumorigenesis. The long term goal of the lab is to apply these findings to clinically relevant issues; to identify prognostic or predictive biomarkers, and to discover novel therapeutic strategies for these cancers.
PhD from State University of New York
MD from Peking University
American journal of cancer research. 2022 Aug; 12(4):1660-1670
Arthritis & rheumatology. 2021 08; 73(8):1514-1522
Cancer discovery. 2021 May; 11(5):1212-1227
Zhongguo gu shang = China journal of orthopaedics & traumatology. 2021 Apr 25; 34(4):382-8
European journal of human genetics. 2019 Oct; 27(10):1589-1598
Archives of pathology & laboratory medicine. 2019 Mar; 143(3):338-348
Oncotarget. 2019 Jan 22; 10(7):707-716